Dr. Silvia Crescioli is a Business Intelligence Creator at The Antibody Society working on business intelligence and educational research projects. Since 2021, she collaborates to the "Antibodies to watch" editorials in mAbs, reviewing antibody therapeutics recently approved or in regulatory review, and forecasting marketing application submissions that might occur the following year. Dr. Crescioli received her PhD in Biomedical Sciences, Experimental Oncology, from the University of Florence in 2014, followed by eight years of post doc at King's College London in Prof. Karagiannis' Cancer Antibody Discovery & Immunotherapy Group, where she is now a visiting Research Fellow.